Personalized Weight Management Oral Compounded GLP-1 Needle-free tablet with personalized expert guided care
Semaglutide, originally developed by Novo Nordisk, is a GLP-1 receptor agonist used in the management of Type 2 diabetes and weight control
Supported by lifestyle improvements like diet and exercise, semaglutide offers the opportunity for sustainable weight loss and healthier living
Greasy, spicy, sugary, and high-fat foods may worsen symptoms
The combination of GLP-1 medications with hormone therapy further enhances weight loss outcomes, particularly for women experiencing the challenges of menopause
To help manage stress, practice relaxation techniques like deep breathing or meditation, and help your body recover and repair with at least 79 hours of sleep each night